From June 23 to 25, 2011, the Mesothelioma Applied Research Foundation will hold an annual international symposium on malignant mesothelioma. The Mesothelioma Applied Research Foundation is a non-profit organization, which provides funds research and services to patients that have mesothelioma. The three-day conference will allow participants to express their concerns regarding mesothelioma research and the ban of the use of asbestos.
The symposium will also educate attendees about the effects of asbestos to health and the existence of mesothelioma, as well as the threat it brings to public and economy. Experts from across the world will share their stories with people in the same situation. Participants can register for the conference via the organization’s website. The website will also contain the agenda for the conference starting in March.
Mesothelioma, is a rare and aggressive form of cancer that claims nearly 3,000 lives in the United States alone. Mesothelioma is caused by the inhalation of asbestos, a fire retardant and insulator that was used widely until the 1970's. However, there are no early symptoms and it can take over 30 years to diagnose mesothelioma. Most victims do not realize they have the disease until it is too late. Due to this lag in diagnosis time, workers in the construction, mining, industrial and even family members of those who work in these fields are still dying from the asbestos-caused disease. Household products, including children’s toys can also contain traces of the dangerous carcinogen.
To learn more about mesothelioma and your legal options contact LegalView for a free mesothelioma law consultation at 866-9LAW-NOW. Our operators are available 24 hours a day 7 days a week. 1-866-952-9669. Visit LegalView for more information about finding a potential mesothelioma lawyer and other information about environmental toxins, including asbestos.
Tags: Asbestos, Mesothelioma
This entry was posted on Tuesday, January 25th, 2011 at 7:08 am and is filed under Asbestos & Mesothelioma. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
No comments:
Post a Comment